Streetbeat News

Price Targets

CMA

RBC Capital analyst Jon Arfstrom has maintained an Outperform rating on Comerica (NYSE:CMA), but lowered the price target from $54 to $50.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:41 pm

IPG

Citigroup analyst Jason Bazinet has maintained a 'Buy' rating on Interpublic Gr of Cos (NYSE:IPG), but lowered the price target from $43 to $40.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:40 pm

LLY

Citigroup analyst Andrew Baum maintains a Buy rating on Eli Lilly (NYSE:LLY) and raises the price target from $525 to $675.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:37 pm

TDOC

Citigroup analyst Daniel Grosslight has maintained a Neutral rating on Teladoc Health (NYSE:TDOC) and lowered the price target from $29 to $21.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:34 pm

T

Citigroup analyst Michael Rollins has maintained a 'Buy' rating on AT&T (NYSE:T) and raised the price target from $17 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:30 pm

BLMN

Barclays analyst Jeffrey Bernstein maintains an Overweight rating on Bloomin Brands (NASDAQ:BLMN) but lowers the price target from $31 to $28.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:11 pm

CHRS

Barclays analyst Balaji Prasad has maintained an Overweight rating on Coherus BioSciences (NASDAQ:CHRS) but lowered the price target from $8 to $7.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:10 pm

CMA

Barclays analyst Jason Goldberg maintains an Underweight rating on Comerica (NYSE:CMA) and has lowered the price target from $52 to $49.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:10 pm

HBAN

Barclays analyst Jason Goldberg maintains an Underweight rating on Huntington Bancshares (NASDAQ:HBAN) and has lowered the price target from $13 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:09 pm

IPG

Barclays analyst Julien Roch maintains an Equal-Weight rating on Interpublic Gr of Cos (NYSE:IPG) and lowers the price target from $38.26 to $35.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:09 pm